Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine

Autores
McKellar, Quintin A.; Sanchez Bruni, Sergio Fabian; Jones, Douglas G.
Año de publicación
2004
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
The rise in incidence of antimicrobial resistance, consumer demands and improved understanding of antimicrobial action has encouraged international agencies to review the use of antimicrobial drugs.  More detailed understanding of relationships between the pharmacokinetics (PK) of antimicrobial drugs in target animal species and their action on target pathogens [pharmacodynamics (PD)] has led to greater sophistication in design of dosage schedules which improve the activity and reduce the selection pressure for resistance in antimicrobial therapy.  This, in turn, may be informative in the pharmaceutical development of antimicrobial drugs and in their selection and clinical utility.  Pharmacokinetic/PD relationships between Area Under the Concentration time curve from zero to 24h (AUC0-24) and Minimum Inhibitory Concentration (MIC), maximum plasma concentration (Cmax) and MIC and time during which plasma concentrations exceed the MIC have been particularly useful in optimising efficacy and minimising resistance.   Antimicrobial drugs have been classified as concentration-dependent where increasing concentrations at the locus of infection improve bacterial kill, or time-dependent where exceeding the MIC for a prolonged percentage of the inter-dosing interval correlates with improved efficacy.  For the latter group increasing the absolute concentration obtained above a threshold does not improve efficacy.  The PK/PD relationship for each group of antimicrobial drugs is ´bug and drug´ specific, although ratios of 125 for AUC0-24:MIC and 10 for Cmax :MIC have been recommended to achieve high efficacy for concentration-dependent antimicrobial drugs, and exceeding MIC by 1-5 multiples for between 40% and 100% of the inter-dosing interval is appropriate for most time-dependent agents.  Fluoroquinolones, aminoglycosides and metronidazole are concentration-dependent and beta lactams, macrolides, lincosamides and glycopeptides time-dependent. For drugs of other classes there is limited and conflicting information on their classification.   Resistance selection may be reduced for concentration-dependent antimicrobials by achieving an AUC0-24:MIC ratio of greater than 100 or a Cmax:MIC ratio of greater than eight. The relationships between time greater than MIC and resistance selection for time-dependent antimicrobials have not been well characterised.
Fil: McKellar, Quintin A.. Royal Veterinary College; Reino Unido
Fil: Sanchez Bruni, Sergio Fabian. Royal Veterinary College; Reino Unido. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Jones, Douglas G.. Royal Veterinary College; Reino Unido
Materia
PHARMACOKINETICS
PAHRMACODYNAMICS
ANTIMICROBIALS
THERAPEUTIC
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/105987

id CONICETDig_43786ba02b1125bc996fc929d6f8cc53
oai_identifier_str oai:ri.conicet.gov.ar:11336/105987
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicineMcKellar, Quintin A.Sanchez Bruni, Sergio FabianJones, Douglas G.PHARMACOKINETICSPAHRMACODYNAMICSANTIMICROBIALSTHERAPEUTIChttps://purl.org/becyt/ford/4.3https://purl.org/becyt/ford/4The rise in incidence of antimicrobial resistance, consumer demands and improved understanding of antimicrobial action has encouraged international agencies to review the use of antimicrobial drugs.  More detailed understanding of relationships between the pharmacokinetics (PK) of antimicrobial drugs in target animal species and their action on target pathogens [pharmacodynamics (PD)] has led to greater sophistication in design of dosage schedules which improve the activity and reduce the selection pressure for resistance in antimicrobial therapy.  This, in turn, may be informative in the pharmaceutical development of antimicrobial drugs and in their selection and clinical utility.  Pharmacokinetic/PD relationships between Area Under the Concentration time curve from zero to 24h (AUC0-24) and Minimum Inhibitory Concentration (MIC), maximum plasma concentration (Cmax) and MIC and time during which plasma concentrations exceed the MIC have been particularly useful in optimising efficacy and minimising resistance.   Antimicrobial drugs have been classified as concentration-dependent where increasing concentrations at the locus of infection improve bacterial kill, or time-dependent where exceeding the MIC for a prolonged percentage of the inter-dosing interval correlates with improved efficacy.  For the latter group increasing the absolute concentration obtained above a threshold does not improve efficacy.  The PK/PD relationship for each group of antimicrobial drugs is ´bug and drug´ specific, although ratios of 125 for AUC0-24:MIC and 10 for Cmax :MIC have been recommended to achieve high efficacy for concentration-dependent antimicrobial drugs, and exceeding MIC by 1-5 multiples for between 40% and 100% of the inter-dosing interval is appropriate for most time-dependent agents.  Fluoroquinolones, aminoglycosides and metronidazole are concentration-dependent and beta lactams, macrolides, lincosamides and glycopeptides time-dependent. For drugs of other classes there is limited and conflicting information on their classification.   Resistance selection may be reduced for concentration-dependent antimicrobials by achieving an AUC0-24:MIC ratio of greater than 100 or a Cmax:MIC ratio of greater than eight. The relationships between time greater than MIC and resistance selection for time-dependent antimicrobials have not been well characterised.Fil: McKellar, Quintin A.. Royal Veterinary College; Reino UnidoFil: Sanchez Bruni, Sergio Fabian. Royal Veterinary College; Reino Unido. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Jones, Douglas G.. Royal Veterinary College; Reino UnidoWiley Blackwell Publishing, Inc2004-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/mswordapplication/pdfhttp://hdl.handle.net/11336/105987McKellar, Quintin A.; Sanchez Bruni, Sergio Fabian; Jones, Douglas G.; Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine; Wiley Blackwell Publishing, Inc; Journal of Veterinary Pharmacology and Therapeutics; 27; 6; 12-2004; 503-5140140-77831365-2885CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2885.2004.00603.xinfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2885.2004.00603.xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:50:17Zoai:ri.conicet.gov.ar:11336/105987instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:50:18.155CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
title Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
spellingShingle Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
McKellar, Quintin A.
PHARMACOKINETICS
PAHRMACODYNAMICS
ANTIMICROBIALS
THERAPEUTIC
title_short Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
title_full Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
title_fullStr Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
title_full_unstemmed Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
title_sort Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine
dc.creator.none.fl_str_mv McKellar, Quintin A.
Sanchez Bruni, Sergio Fabian
Jones, Douglas G.
author McKellar, Quintin A.
author_facet McKellar, Quintin A.
Sanchez Bruni, Sergio Fabian
Jones, Douglas G.
author_role author
author2 Sanchez Bruni, Sergio Fabian
Jones, Douglas G.
author2_role author
author
dc.subject.none.fl_str_mv PHARMACOKINETICS
PAHRMACODYNAMICS
ANTIMICROBIALS
THERAPEUTIC
topic PHARMACOKINETICS
PAHRMACODYNAMICS
ANTIMICROBIALS
THERAPEUTIC
purl_subject.fl_str_mv https://purl.org/becyt/ford/4.3
https://purl.org/becyt/ford/4
dc.description.none.fl_txt_mv The rise in incidence of antimicrobial resistance, consumer demands and improved understanding of antimicrobial action has encouraged international agencies to review the use of antimicrobial drugs.  More detailed understanding of relationships between the pharmacokinetics (PK) of antimicrobial drugs in target animal species and their action on target pathogens [pharmacodynamics (PD)] has led to greater sophistication in design of dosage schedules which improve the activity and reduce the selection pressure for resistance in antimicrobial therapy.  This, in turn, may be informative in the pharmaceutical development of antimicrobial drugs and in their selection and clinical utility.  Pharmacokinetic/PD relationships between Area Under the Concentration time curve from zero to 24h (AUC0-24) and Minimum Inhibitory Concentration (MIC), maximum plasma concentration (Cmax) and MIC and time during which plasma concentrations exceed the MIC have been particularly useful in optimising efficacy and minimising resistance.   Antimicrobial drugs have been classified as concentration-dependent where increasing concentrations at the locus of infection improve bacterial kill, or time-dependent where exceeding the MIC for a prolonged percentage of the inter-dosing interval correlates with improved efficacy.  For the latter group increasing the absolute concentration obtained above a threshold does not improve efficacy.  The PK/PD relationship for each group of antimicrobial drugs is ´bug and drug´ specific, although ratios of 125 for AUC0-24:MIC and 10 for Cmax :MIC have been recommended to achieve high efficacy for concentration-dependent antimicrobial drugs, and exceeding MIC by 1-5 multiples for between 40% and 100% of the inter-dosing interval is appropriate for most time-dependent agents.  Fluoroquinolones, aminoglycosides and metronidazole are concentration-dependent and beta lactams, macrolides, lincosamides and glycopeptides time-dependent. For drugs of other classes there is limited and conflicting information on their classification.   Resistance selection may be reduced for concentration-dependent antimicrobials by achieving an AUC0-24:MIC ratio of greater than 100 or a Cmax:MIC ratio of greater than eight. The relationships between time greater than MIC and resistance selection for time-dependent antimicrobials have not been well characterised.
Fil: McKellar, Quintin A.. Royal Veterinary College; Reino Unido
Fil: Sanchez Bruni, Sergio Fabian. Royal Veterinary College; Reino Unido. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Jones, Douglas G.. Royal Veterinary College; Reino Unido
description The rise in incidence of antimicrobial resistance, consumer demands and improved understanding of antimicrobial action has encouraged international agencies to review the use of antimicrobial drugs.  More detailed understanding of relationships between the pharmacokinetics (PK) of antimicrobial drugs in target animal species and their action on target pathogens [pharmacodynamics (PD)] has led to greater sophistication in design of dosage schedules which improve the activity and reduce the selection pressure for resistance in antimicrobial therapy.  This, in turn, may be informative in the pharmaceutical development of antimicrobial drugs and in their selection and clinical utility.  Pharmacokinetic/PD relationships between Area Under the Concentration time curve from zero to 24h (AUC0-24) and Minimum Inhibitory Concentration (MIC), maximum plasma concentration (Cmax) and MIC and time during which plasma concentrations exceed the MIC have been particularly useful in optimising efficacy and minimising resistance.   Antimicrobial drugs have been classified as concentration-dependent where increasing concentrations at the locus of infection improve bacterial kill, or time-dependent where exceeding the MIC for a prolonged percentage of the inter-dosing interval correlates with improved efficacy.  For the latter group increasing the absolute concentration obtained above a threshold does not improve efficacy.  The PK/PD relationship for each group of antimicrobial drugs is ´bug and drug´ specific, although ratios of 125 for AUC0-24:MIC and 10 for Cmax :MIC have been recommended to achieve high efficacy for concentration-dependent antimicrobial drugs, and exceeding MIC by 1-5 multiples for between 40% and 100% of the inter-dosing interval is appropriate for most time-dependent agents.  Fluoroquinolones, aminoglycosides and metronidazole are concentration-dependent and beta lactams, macrolides, lincosamides and glycopeptides time-dependent. For drugs of other classes there is limited and conflicting information on their classification.   Resistance selection may be reduced for concentration-dependent antimicrobials by achieving an AUC0-24:MIC ratio of greater than 100 or a Cmax:MIC ratio of greater than eight. The relationships between time greater than MIC and resistance selection for time-dependent antimicrobials have not been well characterised.
publishDate 2004
dc.date.none.fl_str_mv 2004-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/105987
McKellar, Quintin A.; Sanchez Bruni, Sergio Fabian; Jones, Douglas G.; Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine; Wiley Blackwell Publishing, Inc; Journal of Veterinary Pharmacology and Therapeutics; 27; 6; 12-2004; 503-514
0140-7783
1365-2885
CONICET Digital
CONICET
url http://hdl.handle.net/11336/105987
identifier_str_mv McKellar, Quintin A.; Sanchez Bruni, Sergio Fabian; Jones, Douglas G.; Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine; Wiley Blackwell Publishing, Inc; Journal of Veterinary Pharmacology and Therapeutics; 27; 6; 12-2004; 503-514
0140-7783
1365-2885
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2885.2004.00603.x
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2885.2004.00603.x
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/msword
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613550901821440
score 13.070432